neuralinatherapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /wp-admin/ Allow:
Meta Tags
Title Neuralina Therapeutics | Home
Description In less than 10 years of treatment with the gold-standard antiparkinsonian medication, Improving medical management of Parkinson’s disease: Improving lives Novel approaches to better manage Parkinson’s disease Get in contact with us In less
Keywords N/A
Server Information
WebSite neuralinatherapeutics faviconneuralinatherapeutics.com
Host IP 165.227.204.142
Location United States
Related Websites
Site Rank
More to Explore
neuralinatherapeutics.com Valuation
US$764
Last updated: 2023-05-18 12:34:20

neuralinatherapeutics.com has Semrush global rank of 0. neuralinatherapeutics.com has an estimated worth of US$ 764, based on its estimated Ads revenue. neuralinatherapeutics.com receives approximately 88 unique visitors each day. Its web server is located in United States, with IP address 165.227.204.142. According to SiteAdvisor, neuralinatherapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$764
Daily Ads Revenue US$0
Monthly Ads Revenue US$21
Yearly Ads Revenue US$254
Daily Unique Visitors 5
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
neuralinatherapeutics.com. 300 A neuralinatherapeutics.com. 300 IP: 165.227.204.142
neuralinatherapeutics.com. 300 NS neuralinatherapeutics.com. 300 NS Record: ns1dns.name.com.
neuralinatherapeutics.com. 300 NS neuralinatherapeutics.com. 300 NS Record: ns2hkt.name.com.
neuralinatherapeutics.com. 300 NS neuralinatherapeutics.com. 300 NS Record: ns3ckl.name.com.
neuralinatherapeutics.com. 300 NS neuralinatherapeutics.com. 300 NS Record: ns4kmw.name.com.
HtmlToTextCheckTime:2023-05-18 12:34:20
Improving medical management of Parkinson’s disease: Improving lives Novel approaches to better manage Parkinson’s disease Get in contact with us In less than 10 years of treatment with the gold-standard antiparkinsonian medication, Levodopa/carbidopa, 9 in 10 individuals with Parkinson’s disease will develop dyskinesia Dyskinesia is a near-inevitable side-effect of Levodopa treatment characterized by erratic, sometimes painful, involuntary movements that worsen with disease progression As many as 9 in 10 people with Parkinson’s disease experience an erratic, sometimes painful involuntary movement side-effect known as dyskinesia within 10 years of treatment with the gold-standard antiparkinsonian medication, Levodopa/carbidopa. Approach By using a unique combination of FDA-approved drugs that alleviate dyskinesia in well-validated preclinical models of Parkinson’s Disease, our therapeutics already have a validated affinity for our targets, a proven safety and tolerability profile in
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sat, 18 Jun 2022 08:28:42 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://neuralinatherapeutics.com/

HTTP/2 200 
server: nginx
date: Sat, 18 Jun 2022 08:28:43 GMT
content-type: text/html; charset=UTF-8
content-length: 63546
vary: Accept-Encoding
x-ua-compatible: IE=edge
link: ; rel="https://api.w.org/", ; rel=shortlink
vary: Accept-Encoding
access-control-allow-origin: *
age: 11923
x-cache: HIT
accept-ranges: bytes
neuralinatherapeutics.com Whois Information
Domain Name: NEURALINATHERAPEUTICS.COM
Registry Domain ID: 2655742003_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.name.com
Registrar URL: http://www.name.com
Updated Date: 2021-11-17T21:49:43Z
Creation Date: 2021-11-17T21:49:42Z
Registry Expiry Date: 2022-11-17T21:49:42Z
Registrar: Name.com, Inc.
Registrar IANA ID: 625
Registrar Abuse Contact Email: abuse@name.com
Registrar Abuse Contact Phone: 7202492374
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1DNS.NAME.COM
Name Server: NS2HKT.NAME.COM
Name Server: NS3CKL.NAME.COM
Name Server: NS4KMW.NAME.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-06-18T08:24:51Z <<<